Phathom Pharmaceuticals, Inc. (PHAT) › Capital ExpendituresPhathom Pharmaceuticals, Inc. (PHAT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2019: $132.0K2020: $1.04M2021: $328.0K2022: $1.04M2023: $1.63M2024: $135.0K2025: $229.0K$229.0K2019Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$229.0K+69.6%2024$135.0K-91.7%2023$1.63M+57.0%2022$1.04M+217.4%2021$328.0K-68.5%2020$1.04M+687.9%2019$132.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share